Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) Unaudited) - USD ($) |
Total |
IPO |
Ratchet |
DGD |
THIO |
Common Stock |
Common Stock
THIO Merger Agreement
|
Common Stock
IPO
|
Common Stock
Ratchet
|
Additional Paid-In Capital |
Additional Paid-In Capital
THIO Merger Agreement
|
Additional Paid-In Capital
IPO
|
Additional Paid-In Capital
Ratchet
|
Additional Paid-In Capital
DGD
|
Accumulated Deficit |
Accumulated other comprehensive income (loss) |
Total MAIA Equity |
Total MAIA Equity
THIO Merger Agreement
|
Total MAIA Equity
IPO
|
Total MAIA Equity
Ratchet
|
Total MAIA Equity
DGD
|
Noncontrolling Interest |
Noncontrolling Interest
THIO Merger Agreement
|
Noncontrolling Interest
DGD
|
Noncontrolling Interest
THIO
|
Receivables from Stockholder |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at Dec. 31, 2020 | $ (1,616,300) | $ 443 | $ 12,599,585 | $ (15,934,113) | $ (3,336,087) | $ 1,719,787 | $ (2,002) | |||||||||||||||||||
Balance, Shares at Dec. 31, 2020 | 4,433,644 | |||||||||||||||||||||||||
Issuance of restricted common shares | 27,500 | $ 2 | 27,498 | 27,500 | ||||||||||||||||||||||
Issuance of restricted common shares, Shares | 15,278 | |||||||||||||||||||||||||
Cancellation of restricted common shares | (1) | $ (1) | (1) | |||||||||||||||||||||||
Cancellation of restricted common shares, Shares | (5,557) | |||||||||||||||||||||||||
Issuance of common shares upon exercise of stock options | 5,400 | 5,400 | 5,400 | |||||||||||||||||||||||
Issuance of common shares upon exercise of stock options, Shares | 3,000 | |||||||||||||||||||||||||
Receipt of stock subscription receivable | 2,002 | 2,002 | 2,002 | |||||||||||||||||||||||
Stock-based compensation expense | 408,608 | $ 64,584 | $ 52,500 | 408,608 | 408,608 | $ 64,584 | $ 52,500 | |||||||||||||||||||
Net loss | (1,525,585) | (1,488,060) | (1,488,060) | (37,525) | ||||||||||||||||||||||
Balance at Mar. 31, 2021 | (2,581,292) | $ 444 | 13,041,091 | (17,422,173) | (4,380,638) | 1,799,346 | ||||||||||||||||||||
Balance, Shares at Mar. 31, 2021 | 4,446,365 | |||||||||||||||||||||||||
Balance at Dec. 31, 2020 | (1,616,300) | $ 443 | 12,599,585 | (15,934,113) | (3,336,087) | 1,719,787 | (2,002) | |||||||||||||||||||
Balance, Shares at Dec. 31, 2020 | 4,433,644 | |||||||||||||||||||||||||
Reclassification of warrant liability to equity | 1,952,000 | |||||||||||||||||||||||||
Net loss | (9,685,477) | |||||||||||||||||||||||||
Balance at Sep. 30, 2021 | 10,230,886 | $ 725 | 36,095,420 | (25,545,259) | 10,230,886 | (320,000) | ||||||||||||||||||||
Balance, Shares at Sep. 30, 2021 | 7,252,364 | |||||||||||||||||||||||||
Balance at Mar. 31, 2021 | (2,581,292) | $ 444 | 13,041,091 | (17,422,173) | (4,380,638) | 1,799,346 | ||||||||||||||||||||
Balance, Shares at Mar. 31, 2021 | 4,446,365 | |||||||||||||||||||||||||
Issuance of stock options to satisfy accrued bonus | 786,531 | 786,531 | 786,531 | |||||||||||||||||||||||
Issuance of stock options to satisfy deferred compensation | 285,418 | 285,418 | 285,418 | |||||||||||||||||||||||
Stock-based compensation expense | 660,048 | 64,584 | $ 52,500 | 660,048 | 660,048 | 64,584 | $ 52,500 | |||||||||||||||||||
Net loss | (2,956,324) | (2,926,648) | (2,926,648) | (29,676) | ||||||||||||||||||||||
Balance at Jun. 30, 2021 | (3,688,535) | $ 444 | 14,773,088 | (20,348,821) | (5,575,289) | 1,886,754 | ||||||||||||||||||||
Balance, Shares at Jun. 30, 2021 | 4,446,365 | |||||||||||||||||||||||||
Issuance of restricted common shares | $ 70 | $ (70) | ||||||||||||||||||||||||
Issuance of restricted common shares, Shares | 700,000 | |||||||||||||||||||||||||
Issuance of common shares upon conversion of convertible notes | 11,001,274 | $ 138 | 11,001,136 | 11,001,274 | ||||||||||||||||||||||
Issuance of common shares upon conversion of convertible notes, Shares | 1,375,228 | |||||||||||||||||||||||||
Issuance of common shares upon conversion of SAFE | 25,000 | 25,000 | 25,000 | |||||||||||||||||||||||
Issuance of common shares upon conversion of SAFE, Shares | 5,208 | |||||||||||||||||||||||||
Issuance of common shares in connection with Equity Financing | 5,484,503 | $ 73 | 5,804,430 | 5,484,503 | (320,000) | |||||||||||||||||||||
Issuance of common shares in connection with Equity Financing, Shares | 725,563 | |||||||||||||||||||||||||
Transaction costs incurred in connection with Equity Financing | (118,332) | (118,332) | (118,332) | |||||||||||||||||||||||
Reclassification of warrant liability to equity | 1,952,000 | 1,952,000 | 1,952,000 | |||||||||||||||||||||||
Stock-based compensation expense | 746,253 | $ 32,291 | 746,253 | 746,253 | 32,291 | |||||||||||||||||||||
Net loss | (5,203,568) | (5,196,438) | (5,196,438) | $ (7,130) | ||||||||||||||||||||||
Dissolution of firm | $ 813,805 | $ 1,098,110 | $ 813,805 | $ 1,098,110 | $ (813,805) | $ (1,098,110) | ||||||||||||||||||||
Balance at Sep. 30, 2021 | 10,230,886 | $ 725 | 36,095,420 | (25,545,259) | 10,230,886 | $ (320,000) | ||||||||||||||||||||
Balance, Shares at Sep. 30, 2021 | 7,252,364 | |||||||||||||||||||||||||
Balance at Dec. 31, 2021 | 9,181,203 | $ 758 | 37,618,438 | (28,437,993) | 9,181,203 | |||||||||||||||||||||
Balance, Shares at Dec. 31, 2021 | 7,584,980 | |||||||||||||||||||||||||
Issuance of common shares upon exercise of stock options | 47,700 | $ 3 | 47,697 | 47,700 | ||||||||||||||||||||||
Issuance of common shares upon exercise of stock options, Shares | 26,500 | |||||||||||||||||||||||||
Issuance of common shares upon exercise of warrants | 110,000 | $ 6 | 109,994 | 110,000 | ||||||||||||||||||||||
Issuance of common shares upon exercise of warrants, Shares | 61,111 | |||||||||||||||||||||||||
Issuance of common shares in connection with Equity Financing | 2,373,561 | $ 27 | 2,373,534 | 2,373,561 | ||||||||||||||||||||||
Issuance of common shares in connection with Equity Financing, Shares | 263,729 | |||||||||||||||||||||||||
Stock-based compensation expense | 713,330 | 713,330 | 713,330 | |||||||||||||||||||||||
Modification of warrant in equity | 450,578 | 450,578 | 450,578 | |||||||||||||||||||||||
Deemed dividend on modification of warrant | (450,578) | (450,578) | (450,578) | |||||||||||||||||||||||
Foreign currency translation adjustment | 1,721 | $ 1,721 | 1,721 | |||||||||||||||||||||||
Net loss | (3,413,845) | (3,413,845) | (3,413,845) | |||||||||||||||||||||||
Balance at Mar. 31, 2022 | 9,013,670 | $ 794 | 40,862,993 | (31,851,838) | 1,721 | 9,013,670 | ||||||||||||||||||||
Balance, Shares at Mar. 31, 2022 | 7,936,320 | |||||||||||||||||||||||||
Balance at Dec. 31, 2021 | $ 9,181,203 | $ 758 | 37,618,438 | (28,437,993) | 9,181,203 | |||||||||||||||||||||
Balance, Shares at Dec. 31, 2021 | 7,584,980 | |||||||||||||||||||||||||
Issuance of common shares upon exercise of stock options, Shares | 36,500 | |||||||||||||||||||||||||
Net loss | $ (11,623,541) | |||||||||||||||||||||||||
Balance at Sep. 30, 2022 | 12,110,667 | $ 1,095 | 52,222,752 | (40,061,534) | (51,646) | 12,110,667 | ||||||||||||||||||||
Balance, Shares at Sep. 30, 2022 | 10,945,904 | |||||||||||||||||||||||||
Balance at Mar. 31, 2022 | 9,013,670 | $ 794 | 40,862,993 | (31,851,838) | 1,721 | 9,013,670 | ||||||||||||||||||||
Balance, Shares at Mar. 31, 2022 | 7,936,320 | |||||||||||||||||||||||||
Issuance of common shares upon exercise of warrants | 275,400 | $ 47 | 275,353 | 275,400 | ||||||||||||||||||||||
Issuance of common shares upon exercise of warrants, Shares | 468,601 | |||||||||||||||||||||||||
Issuance of common shares in connection with Equity Financing | 99,999 | $ 1 | 99,998 | 99,999 | ||||||||||||||||||||||
Issuance of common shares in connection with Equity Financing, Shares | 11,111 | |||||||||||||||||||||||||
Stock-based compensation expense | 584,768 | 584,768 | 584,768 | |||||||||||||||||||||||
Foreign currency translation adjustment | (5,866) | (5,866) | (5,866) | |||||||||||||||||||||||
Net loss | (3,305,883) | (3,305,883) | (3,305,883) | |||||||||||||||||||||||
Balance at Jun. 30, 2022 | 6,662,088 | $ 842 | 41,823,112 | (35,157,721) | (4,145) | 6,662,088 | ||||||||||||||||||||
Balance, Shares at Jun. 30, 2022 | 8,416,032 | |||||||||||||||||||||||||
Issuance of common shares upon exercise of stock options | 18,000 | $ 1 | 17,999 | 18,000 | ||||||||||||||||||||||
Issuance of common shares upon exercise of stock options, Shares | 10,000 | |||||||||||||||||||||||||
Issuance of common shares | $ 8,750,095 | $ 1,099,360 | $ 230 | $ 22 | $ 8,749,865 | $ 1,099,338 | $ 8,750,095 | $ 1,099,360 | ||||||||||||||||||
Issuance of common shares, Shares | 2,300,000 | 219,872 | ||||||||||||||||||||||||
Stock-based compensation expense | 532,438 | 532,438 | 532,438 | |||||||||||||||||||||||
Foreign currency translation adjustment | (47,501) | (47,501) | (47,501) | |||||||||||||||||||||||
Net loss | (4,903,813) | (4,903,813) | (4,903,813) | |||||||||||||||||||||||
Balance at Sep. 30, 2022 | $ 12,110,667 | $ 1,095 | $ 52,222,752 | $ (40,061,534) | $ (51,646) | $ 12,110,667 | ||||||||||||||||||||
Balance, Shares at Sep. 30, 2022 | 10,945,904 |